CAPR
NASDAQ · Biotechnology
Capricor Therapeutics Inc
$29.10
-2.07 (-6.64%)
Analyst Consensus
Strong Buy
16
Analysts
High
Coverage
Price Target
Analyst Price Target
+114.6% upside
Low Target
$34.96
Average Target
$62.44
High Target
$82.04
Current Price
$29.10
Current
$29.10
$29.10
Target
$62.44
$62.44
$34.96
$62.44 avg
$82.04
Scenario Analysis
Bear Case
$34.96
20.1%
Low target
Base Case
$62.44
+114.6%
Avg target
Bull Case
$82.04
+181.9%
High target
Risk/Reward
9.0x
Highly favorable
Price in Context
52-Week High
$40.37
-27.9% from high
52-Week Low
$4.30
+576.7% from low
Target vs 52W High
$62.44
+54.7% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Buy | 39 | 69% | $257.58 | +24.3% |
| AMGN | Hold | 42 | 50% | $190.87 | -46.1% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +162.3% |
| VRTX | Strong Buy | 39 | 79% | $438.34 | -3.7% |
| REGN | Strong Buy | 36 | 75% | $76.80 | -89.8% |
| ALNY | Strong Buy | 36 | 78% | $102.31 | -68.9% |
| INSM | Strong Buy | 26 | 92% | $143.40 | -3.3% |
| NTRA | Strong Buy | 27 | 89% | $142.91 | -27.6% |